GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GP Pharm SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0482
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insipidus; endometriosis, women fertility and precocious puberty, among others. It provides products for acromegaly and gastro esophageal variceal bleed; acute hemorrhages of the upper gastro enteric tract; colorectal cancer; ovarian, lung, pancreas and metastatic breast cancers; and for preventing uterine atony following the infant delivery through caesarean section, among others. GP Pharm is developing its pre-clinical candidates in the areas of oncology, central nervous system disorders and musculoskeletal disorders. The company also offers contract development and contract manufacturing of pharmaceutical injectables for sterile drug products. The company has a manufacturing facility at Catalonia, Barcelona, and others. GP Pharm is headquartered in Barcelona, Spain.

GP Pharm SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GP Pharm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GP Pharm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GP Pharm SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hemispherx Biopharma Enters into Distribution Agreement with GP Pharm for Ampligen 10
Licensing Agreements 11
PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 11
Hikma Pharma Enters into Licensing and Supply Agreement with GP Pharm 12
Lee’s Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 13
Hikma Pharma Enters Into Licensing Agreement With GP Pharm For Lutrate 1 Month 14
GP Pharm SA – Key Competitors 15
GP Pharm SA – Key Employees 16
GP Pharm SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GP Pharm SA, Pharmaceuticals & Healthcare, Key Facts 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GP Pharm SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GP Pharm SA, Deals By Therapy Area, 2012 to YTD 2018 8
GP Pharm SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Enters into Distribution Agreement with GP Pharm for Ampligen 10
PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 11
Hikma Pharma Enters into Licensing and Supply Agreement with GP Pharm 12
Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 13
Hikma Pharma Enters Into Licensing Agreement With GP Pharm For Lutrate 1 Month 14
GP Pharm SA, Key Competitors 15
GP Pharm SA, Key Employees 16
GP Pharm SA, Other Locations 17

List of Figures
GP Pharm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GP Pharm SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GP Pharm SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VP Bank AG (VPBN):企業の財務・戦略的SWOT分析
    Summary VP Bank AG (VP Bank) is a financial service provider that offers banking services, asset management, and portfolio advisory services to institutional and private investors. The company provides a wide variety of house solutions, third-party financial products through a network of strategical …
  • Edgemont Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Edgemont Pharmaceuticals LLC (Edgemont) is a pharmaceutical company that develops, acquires, and markets products for the treatment of psychiatric disorders. The company focuses on the development of novel drug formulations and therapies in the field of neuroscience. Its portfolio of product …
  • Magnetek Inc:企業の戦略的SWOT分析
    Magnetek Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Innocoll AG:医療機器:M&Aディール及び事業提携情報
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HC …
  • BioCardia Inc:製品パイプライン分析
    Summary BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiA …
  • Spur Corporation Limited
    Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • KDDI Corporation:企業の戦略・SWOT・財務情報
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • KPMG International:企業の戦略・SWOT・財務情報
    KPMG International - Strategy, SWOT and Corporate Finance Report Summary KPMG International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務分析
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務分析
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aetna Inc:企業の戦略・SWOT・財務情報
    Aetna Inc - Strategy, SWOT and Corporate Finance Report Summary Aetna Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Landsvirkjun hf-エネルギー分野:企業M&A・提携分析
    Summary Landsvirkjun hf (Landsvirkjun) is a state-owned energy utility that conducts the generation and transmission of electricity in Iceland. It generates electricity through several renewable sources such as hydro, geothermal, and wind. Through subsidiaries, the company also offers telecommunicat …
  • Schmolz + Bickenbach AG:企業の戦略・SWOT・財務情報
    Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report Summary Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tsumura & Co.:企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Archer Ltd (ARCHER):石油・ガス:M&Aディール及び事業提携情報
    Summary Archer Ltd (Archer) is an oilfield services company. It provides drilling services, well integrity and intervention, plug and abandonment and decommissioning. Its drilling and work-over services include platform drilling, land drilling, modular rigs, drilling fluids, solids control, engineer …
  • Banque Cantonale Vaudoise:企業の戦略・SWOT・財務分析
    Banque Cantonale Vaudoise - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Biowa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology inc …
  • Aerie Pharmaceuticals Inc (AERI):製薬・医療:M&Aディール及び事業提携情報
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the redu …
  • comdirect bank AG:企業の戦略・SWOT・財務情報
    comdirect bank AG - Strategy, SWOT and Corporate Finance Report Summary comdirect bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆